Literature DB >> 10899959

Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebal cortex plasma membranes.

A G Douen1, K Akiyama, M J Hogan, F Wang, L Dong, A K Chow, A Hakim.   

Abstract

We previously reported a 50% reduction in cortical infarct volume following transient focal cerebral ischemia in rats preconditioned 3 days earlier with cortical spreading depression (CSD). The mechanism of the protective effect of prior CSD remains unknown. Recent studies demonstrate reversal of excitatory amino acid transporters (EAATs) to be a principal cause for elevated extracellular glutamate levels during cerebral ischemia. The present study measured the effect of CSD preconditioning on (a) intraischemic glutamate levels and (b) regulation of glutamate transporters within the ischemic cortex of the rat. Three days following either CSD or sham preconditioning, rats were subjected to 200 min of focal cerebral ischemia, and extracellular glutamate concentration was measured by in vivo microdialysis. Cortical glutamate exposure decreased 70% from 1,772.4 +/- 1,469.2 microM-min in sham-treated (n = 8) to 569.0 +/- 707.8 microM-min in CSD-treated (n = 13) rats (p <0.05). The effect of CSD preconditioning on glutamate transporter levels in plasma membranes (PMs) prepared from rat cerebral cortex was assessed by western blot analysis. Down-regulation of the glial glutamate transporter isoforms EAAT2 and EAAT1 from the PM fraction was observed at 1, 3, and 7 days but not at 0 or 21 days after CSD. Semiquantitative lane analysis showed a maximal decrease of 90% for EAAT2 and 50% for EAAT1 at 3 days post-CSD. The neuronal isoform EAAT3 was unaffected by CSD. This period of down-regulation coincides with the time frame reported for induced ischemic tolerance. These data are consistent with reversal of glutamate transporter function contributing to glutamate release during ischemia and suggest that down-regulation of these transporters may contribute to ischemic tolerance induced by CSD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899959     DOI: 10.1046/j.1471-4159.2000.0750812.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

1.  Brain tissue responses to ischemia.

Authors:  J M Lee; M C Grabb; G J Zipfel; D W Choi
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

3.  The effects of estradiol on estrogen receptor and glutamate transporter expression in organotypic hippocampal cultures exposed to oxygen--glucose deprivation.

Authors:  Helena Cimarosti; Ross D O'Shea; Nicole M Jones; Ana Paula Horn; Fabrício Simão; Lauren L Zamin; Melissa Nassif; Rudimar Frozza; Carlos Alexandre Netto; Philip M Beart; Christianne Salbego
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

Review 4.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

5.  Functional significance of the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures.

Authors:  Tatsuro Kosugi; Koichi Kawahara; Takeshi Yamada; Takayuki Nakajima; Motoki Tanaka
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

6.  Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury.

Authors:  Lai Ming Yung; Ying Wei; Tao Qin; Yumei Wang; Charles D Smith; Christian Waeber
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

Review 7.  Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance.

Authors:  Miguel A Perez-Pinzon
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2006-08-30       Impact factor: 2.320

Review 8.  The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy.

Authors:  Jed A Hartings; C William Shuttleworth; Sergei A Kirov; Cenk Ayata; Jason M Hinzman; Brandon Foreman; R David Andrew; Martyn G Boutelle; K C Brennan; Andrew P Carlson; Markus A Dahlem; Christoph Drenckhahn; Christian Dohmen; Martin Fabricius; Eszter Farkas; Delphine Feuerstein; Rudolf Graf; Raimund Helbok; Martin Lauritzen; Sebastian Major; Ana I Oliveira-Ferreira; Frank Richter; Eric S Rosenthal; Oliver W Sakowitz; Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Anthony J Strong; Anja Urbach; M Brandon Westover; Maren Kl Winkler; Otto W Witte; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

9.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

Review 10.  Cortical spreading depression modifies components of the inflammatory cascade.

Authors:  Charlie S Thompson; Antoine M Hakim
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.